Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Conditions

• Systemic Lupus Erythematosus (Sle)
• Primary Ovarian Insufficiency (Poi)

Sponsor

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)